NCT07743190
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07743190
Title A Phase II Study of Biomarker-Guided De-escalation Using Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Early-Stage Triple Negative Breast Cancer (TNBC) Patients With High Tumor-Infiltrating Lymphocytes (TILs) (NeoTILs)
Acronym NeoTILs
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Medical University of South Carolina
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.